Articles published by Gilead Sciences, Inc.![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Business Wire
Tickers
GILD
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() Via Business Wire
Tickers
GILD
![]()
Gilead Sciences to Present at Upcoming Investor Conferences
April 26, 2022
Via Business Wire
Tickers
GILD
![]() ![]() ![]() ![]()
Gilead Sciences to Release First Quarter 2022 Financial Results on Thursday, April 28, 2022
April 14, 2022
Via Business Wire
Tickers
GILD
![]() Via Business Wire
Tickers
GILD
![]() ![]() ![]() ![]() ![]()
Biktarvy® Demonstrates High Efficacy and Durable Viral Suppression at Five Years, in Treatment-Naïve Adults
February 11, 2022
Via Business Wire
Tickers
GILD
![]() ![]()
Gilead to Present Latest Antiviral Research and Development Data at CROI 2022 Addressing Urgent Global Needs
February 08, 2022
Via Business Wire
Tickers
GILD
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|